These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 33376111)

  • 1. Antiglycolipid antibodies in Guillain-Barré and Fisher syndromes: discovery, current status and future perspective.
    Kusunoki S; Willison HJ; Jacobs BC
    J Neurol Neurosurg Psychiatry; 2021 Mar; 92(3):311-318. PubMed ID: 33376111
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to Glycolipids in Guillain-Barré Syndrome, Miller Fisher Syndrome and Related Autoimmune Neurological Diseases.
    Kusunoki S
    Adv Neurobiol; 2023; 29():479-495. PubMed ID: 36255685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibodies against gangliosides and ganglioside complexes in Guillain-Barré syndrome: new aspects of research.
    Kusunoki S; Kaida K; Ueda M
    Biochim Biophys Acta; 2008 Mar; 1780(3):441-4. PubMed ID: 17976386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antiglycolipid antibody in inflammatory neuropathy].
    Kusunoki S
    Rinsho Shinkeigaku; 1995 Dec; 35(12):1370-2. PubMed ID: 8752399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Guillain-Barré syndrome and related diseases after influenza virus infection.
    Yamana M; Kuwahara M; Fukumoto Y; Yoshikawa K; Takada K; Kusunoki S
    Neurol Neuroimmunol Neuroinflamm; 2019 Jul; 6(4):e575. PubMed ID: 31355311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiganglioside, antiganglioside-complex, and antiglycolipid-complex antibodies in immune-mediated neuropathies.
    Goodfellow JA; Willison HJ
    Curr Opin Neurol; 2016 Oct; 29(5):572-80. PubMed ID: 27427992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Guillain-Barré Syndrome.
    Kaida K
    Adv Exp Med Biol; 2019; 1190():323-331. PubMed ID: 31760653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of testing kits of anti-ganglioside antibody: clinical utility in Guillain-Barré and Fisher syndromes].
    Akiyama M; Koga M; Yoshino H; Hamaoka A; Noguchi Y; Hirata K; Yuki N
    No To Shinkei; 2006 Jun; 58(6):477-81. PubMed ID: 16856515
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic disialylgalactose immunoadsorbents deplete anti-GQ1b antibodies from autoimmune neuropathy sera.
    Willison HJ; Townson K; Veitch J; Boffey J; Isaacs N; Andersen SM; Zhang P; Ling CC; Bundle DR
    Brain; 2004 Mar; 127(Pt 3):680-91. PubMed ID: 14960498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antiganglioside antibodies in the pathogenesis of autoimmune neuropathies].
    Kusunoki S
    Rinsho Shinkeigaku; 1999 Jan; 39(1):93-5. PubMed ID: 10377820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Close association of IgA anti-ganglioside antibodies with antecedent Campylobacter jejuni infection in Guillain-Barré and Fisher's syndromes.
    Koga M; Yuki N; Takahashi M; Saito K; Hirata K
    J Neuroimmunol; 1998 Jan; 81(1-2):138-43. PubMed ID: 9521615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immune-mediated neuropathy].
    Kusunoki S
    Rinsho Shinkeigaku; 2008 Nov; 48(11):1023-5. PubMed ID: 19198151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis of Guillain-Barré syndrome.
    Hughes RA; Hadden RD; Gregson NA; Smith KJ
    J Neuroimmunol; 1999 Dec; 100(1-2):74-97. PubMed ID: 10695718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A New Aspect of Anti-Glycolipid Antibodies in Guillain-Barré Syndrome: Ca
    Chiba A; Uchibori A; Gyohda A
    Brain Nerve; 2018 Apr; 70(4):405-417. PubMed ID: 29632288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
    Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
    J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to gangliosides and ganglioside complexes in Guillain-Barré syndrome and Fisher syndrome: mini-review.
    Kaida K; Kusunoki S
    J Neuroimmunol; 2010 Jun; 223(1-2):5-12. PubMed ID: 20172612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside complexes containing GQ1b as targets in Miller Fisher and Guillain-Barre syndromes.
    Kanzaki M; Kaida K; Ueda M; Morita D; Hirakawa M; Motoyoshi K; Kamakura K; Kusunoki S
    J Neurol Neurosurg Psychiatry; 2008 Oct; 79(10):1148-52. PubMed ID: 18339728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-ganglioside antibody and neuropathy: review of our research.
    Yuki N
    J Peripher Nerv Syst; 1998; 3(1):3-18. PubMed ID: 10959233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antiganglioside complex antibody].
    Hongo Y; Kaida K
    Nihon Rinsho; 2013 May; 71(5):839-44. PubMed ID: 23777091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
    Tagawa Y; Matsumoto Y; Yuki N
    No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.